Study title: Abacavir pharmacokinetics during chronic therapy in HIV-1 infected adolescents and young adults
Type of medicine: Centrally authorised medicines | |||||
Therapeutic area: Virus Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: abacavir | |||||
ATC code: J05AF06 | |||||
Document link: | |||||
Document date: | |||||
Study number: PACTGP1052 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | Y |